Request Sample
Request Methodology
Description
Tourette Syndrome Treatment Market size was valued at USD x billion in 2021, growing at a CAGR of 10.2% during the forecast period 2022-28. Tourette syndrome is one type of neurological disorder characterized by stereotypic, repetitive involuntary movements known as tics. This syndrome usually affects the people of age between 2 to 15 years. Tourette syndrome 4 times more common in males than females. The patents may experience simple ticks include eye blinking, head jerking, eye darting or nose twitching. Complex ticks include obscene gesturing, hopping, touching or smelling the objects and stepping in a certain pattern. Companies in global Tourette syndrome management market are actively involving in the R&D activities in development of new treatment options to treat the syndrome. Furthermore, collaborations and acquisitions also the key strategies adopted by the companies to maximize their market share. For instance, Neurocrine’s INGREZZA is under phase 2 clinical trials for the treatment of Tourette syndrome. COVID-19 is an unprecedented worldwide public health crisis that has impacted practically every business, and its long-term repercussions are expected to have an influence on industry growth during the projection period. Our continuous study is enhancing our research approach to guarantee that fundamental COVID-19 concerns and potential solutions are included. The research examines COVID-19 in light of changes in consumer behaviour and demand, purchasing patterns, supply chain re-routing, market dynamics, and government involvement. The Tourette Syndrome Treatment Market report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.
